Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016.

Ercibengoa M, Càmara J, Tubau F, García-Somoza D, Galar A, Martín-Rabadán P, Marin M, Mateu L, García-Olivé I, Prat C, Cilloniz C, Torres A, Pedro-Botet ML, Ardanuy C, Muñoz P, Marimón JM.

Int J Infect Dis. 2019 Nov 4;90:161-166. doi: 10.1016/j.ijid.2019.10.032. [Epub ahead of print]

2.

Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an In Vitro Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae.

Ribera A, Benavent E, El-Haj C, Gomez-Junyent J, Tubau F, Rigo-Bonnin R, Ariza J, Murillo O.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01230-19. doi: 10.1128/AAC.01230-19. Print 2019 Nov.

PMID:
31481437
3.

A novel genomic island harbouring lsa(E) and lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics.

Berbel D, Càmara J, García E, Tubau F, Guérin F, Giard JC, Domínguez MÁ, Cattoir V, Ardanuy C.

Int J Antimicrob Agents. 2019 Nov;54(5):647-651. doi: 10.1016/j.ijantimicag.2019.08.019. Epub 2019 Aug 30.

PMID:
31476434
4.

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Rodriguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A.

Clin Microbiol Infect. 2019 Jul 6. pii: S1198-743X(19)30389-1. doi: 10.1016/j.cmi.2019.06.034. [Epub ahead of print]

PMID:
31288102
5.

The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes.

Benavent E, Murillo O, Grau I, Laporte-Amargos J, Gomez-Junyent J, Soldevila L, Tubau F, Ariza J, Pallares R.

Diabetes Care. 2019 Jul;42(7):e110-e112. doi: 10.2337/dc18-2294. Epub 2019 May 21. No abstract available.

PMID:
31221706
6.

Impact of pre-hospital antibiotic therapy on mortality in invasive meningococcal disease: a propensity score study.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Viladrich PF.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1671-1676. doi: 10.1007/s10096-019-03599-8. Epub 2019 May 28.

PMID:
31140070
7.

Invasive Meningococcal Disease: What We Should Know, Before It Comes Back.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Fernandez Viladrich P.

Open Forum Infect Dis. 2019 Feb 7;6(3):ofz059. doi: 10.1093/ofid/ofz059. eCollection 2019 Mar.

8.

Identification of polysaccharide capsules among extensively drug-resistant genitourinary Haemophilus parainfluenzae isolates.

González-Díaz A, Tubau F, Pinto M, Sierra Y, Cubero M, Càmara J, Ayats J, Bajanca-Lavado P, Ardanuy C, Marti S.

Sci Rep. 2019 Mar 14;9(1):4481. doi: 10.1038/s41598-019-40812-2.

9.

Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).

Cantón R, Loza E, Aznar J, Castillo FJ, Cercenado E, Fraile-Ribot PA, González-Romo F, López-Hontangas JL, Rodríguez-Lozano J, Suárez-Barrenechea AI, Tubau F, Díaz-Regañón J, López-Mendoza D; SMART-Spain Working Group.

Rev Esp Quimioter. 2019 Apr;32(2):145-155. Epub 2019 Feb 13.

10.

Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.

Gómez-Junyent J, Benavent E, Sierra Y, El Haj C, Soldevila L, Torrejón B, Rigo-Bonnin R, Tubau F, Ariza J, Murillo O.

Int J Antimicrob Agents. 2019 May;53(5):612-619. doi: 10.1016/j.ijantimicag.2019.01.010. Epub 2019 Jan 23.

PMID:
30682497
11.

Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections.

Rigo-Bonnin R, Gomez-Junyent J, García-Tejada L, Benavent E, Soldevila L, Tubau F, Murillo O.

Clin Chim Acta. 2019 Jan;488:50-60. doi: 10.1016/j.cca.2018.10.034. Epub 2018 Oct 30.

PMID:
30385280
12.

Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016.

Shoji H, Vázquez-Sánchez DA, Gonzalez-Diaz A, Cubero M, Tubau F, Santos S, García-Somoza D, Liñares J, Yuste J, Martí S, Ardanuy C.

Infect Drug Resist. 2018 Sep 4;11:1387-1400. doi: 10.2147/IDR.S165093. eCollection 2018.

13.

Evolution of the β-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.

Càmara J, Cubero M, Martín-Galiano AJ, García E, Grau I, Nielsen JB, Worning P, Tubau F, Pallarés R, Domínguez MÁ, Kilian M, Liñares J, Westh H, Ardanuy C.

J Antimicrob Chemother. 2018 Nov 1;73(11):2941-2951. doi: 10.1093/jac/dky305.

PMID:
30165641
14.

Detection of the Novel optrA Gene Among Linezolid-Resistant Enterococci in Barcelona, Spain.

Càmara J, Camoez M, Tubau F, Pujol M, Ayats J, Ardanuy C, Domínguez MÁ.

Microb Drug Resist. 2019 Jan/Feb;25(1):87-93. doi: 10.1089/mdr.2018.0028. Epub 2018 Aug 28.

PMID:
30153086
15.

Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).

Cantón R, Loza E, Aznar J, Barrón-Adúriz R, Calvo J, Castillo FJ, Cercenado E, Cisterna R, González-Romo F, López-Hontangas JL, Suárez-Barrenechea AI, Tubau F, Molloy B, López-Mendoza D; SMART-Spain Working Group.

Rev Esp Quimioter. 2018 Apr;31(2):136-145. Epub 2018 Mar 12.

16.

Analysis of mortality in a cohort of 650 cases of bacteremic osteoarticular infections.

Gomez-Junyent J, Murillo O, Grau I, Benavent E, Ribera A, Cabo X, Tubau F, Ariza J, Pallares R.

Semin Arthritis Rheum. 2018 Oct;48(2):327-333. doi: 10.1016/j.semarthrit.2018.01.007. Epub 2018 Jan 31.

PMID:
29429761
17.

Endocarditis associated with vertebral osteomyelitis and septic arthritis of the axial skeleton.

Murillo O, Grau I, Gomez-Junyent J, Cabrera C, Ribera A, Tubau F, Peña C, Ariza J, Pallares R.

Infection. 2018 Apr;46(2):245-251. doi: 10.1007/s15010-018-1121-9. Epub 2018 Feb 2.

PMID:
29396671
18.

Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.

El Haj C, Murillo O, Ribera A, Lloberas N, Gómez-Junyent J, Tubau F, Fontova P, Cabellos C, Ariza J.

Int J Antimicrob Agents. 2018 Jun;51(6):854-861. doi: 10.1016/j.ijantimicag.2018.01.014. Epub 2018 Jan 31.

PMID:
29374577
19.

Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use.

Ribera A, Soldevila L, Rigo-Bonnin R, Tubau F, Padullés A, Gómez-Junyent J, Ariza J, Murillo O.

Infection. 2018 Apr;46(2):239-244. doi: 10.1007/s15010-018-1116-6. Epub 2018 Jan 23.

PMID:
29363049
20.

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection.

Shaw E, Rombauts A, Tubau F, Padullés A, Càmara J, Lozano T, Cobo-Sacristán S, Sabe N, Grau I, Rigo-Bonnin R, Dominguez MA, Carratalà J.

J Antimicrob Chemother. 2018 Apr 1;73(4):1104-1106. doi: 10.1093/jac/dkx496. No abstract available.

PMID:
29272413
21.

Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02352-17. doi: 10.1128/AAC.02352-17. Print 2018 Jan. No abstract available.

22.

Molecular Epidemiology of Klebsiella pneumoniae Strains Causing Bloodstream Infections in Adults.

Cubero M, Grau I, Tubau F, Pallarés R, Domínguez MÁ, Liñares J, Ardanuy C.

Microb Drug Resist. 2018 Sep;24(7):949-957. doi: 10.1089/mdr.2017.0107. Epub 2017 Dec 11.

PMID:
29227744
23.

The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes.

Shoji H, Domenech A, Simonetti AF, González A, García-Somoza D, Cubero M, Martí S, Maeda M, Tubau F, Liñares J, Domínguez MA, Carratalà J, Ardanuy C.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e00787-17. doi: 10.1128/JCM.00787-17. Print 2018 Feb.

24.

Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study.

Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, García D, Tubau F, Martínez-Sánchez JM, Carratalà J, Pujol M.

J Hosp Infect. 2018 May;99(1):48-54. doi: 10.1016/j.jhin.2017.11.002. Epub 2017 Nov 8.

PMID:
29128346
25.

Control of endemic multidrug-resistant Gram-negative bacteria after removal of sinks and implementing a new water-safe policy in an intensive care unit.

Shaw E, Gavaldà L, Càmara J, Gasull R, Gallego S, Tubau F, Granada RM, Ciercoles P, Dominguez MA, Mañez R, Carratalà J, Pujol M.

J Hosp Infect. 2018 Mar;98(3):275-281. doi: 10.1016/j.jhin.2017.10.025. Epub 2017 Nov 28.

PMID:
29104124
26.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01589-17. doi: 10.1128/AAC.01589-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

27.

Invasive meningococcal disease: Impact of short course therapy. A DOOR/RADAR study.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Fernandez-Viladrich P.

J Infect. 2017 Nov;75(5):420-425. doi: 10.1016/j.jinf.2017.08.009. Epub 2017 Aug 25.

PMID:
28847701
28.

Drawbacks of the use of cotrimoxazole in foreign-body infections.

El Haj C, Ribera A, Lloberas N, Tubau F, Ariza J, Murillo O.

Enferm Infecc Microbiol Clin. 2018 Jun - Jul;36(6):362-365. doi: 10.1016/j.eimc.2017.07.005. Epub 2017 Aug 14. English, Spanish.

PMID:
28818482
29.

Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways.

Rodríguez-Arce I, Martí S, Euba B, Fernández-Calvet A, Moleres J, López-López N, Barberán M, Ramos-Vivas J, Tubau F, Losa C, Ardanuy C, Leiva J, Yuste JE, Garmendia J.

Front Cell Infect Microbiol. 2017 Jun 20;7:266. doi: 10.3389/fcimb.2017.00266. eCollection 2017.

30.

Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.

Oriol I, Sabé N, Simonetti AF, Lladó L, Manonelles A, González J, Tubau F, Carratalà J.

Transpl Int. 2017 Sep;30(9):903-913. doi: 10.1111/tri.12984. Epub 2017 Jul 13.

31.

Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma.

Rigo-Bonnin R, Ribera A, Arbiol-Roca A, Cobo-Sacristán S, Padullés A, Murillo Ò, Shaw E, Granada R, Pérez-Fernández XL, Tubau F, Alía P.

Clin Chim Acta. 2017 May;468:215-224. doi: 10.1016/j.cca.2017.03.009. Epub 2017 Mar 10.

PMID:
28288784
32.

Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model.

Gómez-Zorrilla S, Calatayud L, Juan C, Cabot G, Tubau F, Oliver A, Dominguez MA, Ariza J, Peña C.

Int J Antimicrob Agents. 2017 Feb;49(2):198-203. doi: 10.1016/j.ijantimicag.2016.10.016. Epub 2016 Nov 28.

PMID:
27939091
33.

Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: A prospective cohort study.

Royo-Cebrecos C, Gudiol C, García J, Tubau F, Laporte J, Ardanuy C, Antonio M, Marin M, Gornals JB, Carratalà J.

J Infect. 2017 Feb;74(2):172-178. doi: 10.1016/j.jinf.2016.10.008. Epub 2016 Nov 5.

PMID:
27826062
34.

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Plesiat P, Oliver A.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7415-7423. Print 2016 Dec.

35.

Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.

Gómez-Zorrilla S, Morandeira F, Castro MJ, Tubau F, Periche E, Cañizares R, Dominguez MA, Ariza J, Peña C.

Microb Drug Resist. 2017 Jun;23(4):523-530. doi: 10.1089/mdr.2016.0144. Epub 2016 Oct 18.

36.

The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?

El Haj C, Murillo O, Ribera A, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.

Med Microbiol Immunol. 2017 Feb;206(1):31-39. doi: 10.1007/s00430-016-0479-5. Epub 2016 Sep 17.

PMID:
27639707
37.

The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation.

Oriol I, Lladó L, Vila M, Baliellas C, Tubau F, Sabé N, Fabregat J, Carratalà J.

PLoS One. 2016 Aug 11;11(8):e0160701. doi: 10.1371/journal.pone.0160701. eCollection 2016.

38.

Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.

Gómez-Zorrilla S, Juan C, Cabot G, Camoez M, Tubau F, Oliver A, Dominguez MA, Ariza J, Peña C.

Int J Antimicrob Agents. 2016 May;47(5):368-74. doi: 10.1016/j.ijantimicag.2016.02.010. Epub 2016 Mar 24.

PMID:
27079153
39.

Clinical findings of bacteremic septic arthritis according to the site of acquisition: The overlap between health care-related and community- and nosocomial-acquired cases.

Murillo O, Gomez-Junyent J, Grau I, Ribera A, Cabrera C, Pedrero S, Tubau F, Nolla JM, Ariza J, Pallares R.

Eur J Intern Med. 2016 Mar;28:38-42. doi: 10.1016/j.ejim.2015.11.013. Epub 2015 Nov 27.

PMID:
26639050
40.

Identification of Haemophilus haemolyticus in clinical samples and characterization of their mechanisms of antimicrobial resistance.

Marti S, Puig C, de la Campa AG, Tirado-Velez JM, Tubau F, Domenech A, Calatayud L, Garcia-Somoza D, Ayats J, Liñares J, Ardanuy C.

J Antimicrob Chemother. 2016 Jan;71(1):80-4. doi: 10.1093/jac/dkv307. Epub 2015 Oct 15.

PMID:
26472767
41.

Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013).

Cubero M, Grau I, Tubau F, Pallarés R, Dominguez MA, Liñares J, Ardanuy C.

Clin Microbiol Infect. 2016 Feb;22(2):154-160. doi: 10.1016/j.cmi.2015.09.025. Epub 2015 Oct 8.

42.

Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.

Vivas M, Force E, El Haj C, Tubau F, Ariza J, Cabellos C.

J Microbiol Immunol Infect. 2017 Aug;50(4):435-439. doi: 10.1016/j.jmii.2015.07.014. Epub 2015 Sep 9.

43.

Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams.

Ribera A, Benavent E, Lora-Tamayo J, Tubau F, Pedrero S, Cabo X, Ariza J, Murillo O.

J Antimicrob Chemother. 2015 Dec;70(12):3357-65. doi: 10.1093/jac/dkv281. Epub 2015 Sep 28.

PMID:
26419763
44.

Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.

Cubero M, Cuervo G, Dominguez MÁ, Tubau F, Martí S, Sevillano E, Gallego L, Ayats J, Peña C, Pujol M, Liñares J, Ardanuy C.

BMC Microbiol. 2015 Sep 3;15:177. doi: 10.1186/s12866-015-0510-9.

45.

Prospective observational study of prior rectal colonization status as a predictor for subsequent development of Pseudomonas aeruginosa clinical infections.

Gómez-Zorrilla S, Camoez M, Tubau F, Cañizares R, Periche E, Dominguez MA, Ariza J, Peña C.

Antimicrob Agents Chemother. 2015 Sep;59(9):5213-9. doi: 10.1128/AAC.04636-14. Epub 2015 Jun 15.

46.

Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.

El Haj C, Murillo O, Ribera A, Vivas M, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.

Int J Antimicrob Agents. 2015 Aug;46(2):189-95. doi: 10.1016/j.ijantimicag.2015.04.004. Epub 2015 May 21.

PMID:
26051988
47.

Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.

Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos C.

Int J Antimicrob Agents. 2015 Jul;46(1):28-32. doi: 10.1016/j.ijantimicag.2015.01.014. Epub 2015 Mar 6.

PMID:
25813395
48.

The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century.

Murillo O, Grau I, Lora-Tamayo J, Gomez-Junyent J, Ribera A, Tubau F, Ariza J, Pallares R.

Clin Microbiol Infect. 2015 Mar;21(3):254.e1-8. doi: 10.1016/j.cmi.2014.09.007. Epub 2014 Oct 12.

49.

Draft Genome Sequence of the Quorum-Sensing and Biofilm-Producing Pseudomonas aeruginosa Strain Pae221, Belonging to the Epidemic High-Risk Clone Sequence Type 274.

Ocampo-Sosa AA, Fernández-Martínez M, Cabot G, Peña C, Tubau F, Oliver A, Martínez-Martínez L.

Genome Announc. 2015 Jan 15;3(1). pii: e01343-14. doi: 10.1128/genomeA.01343-14.

50.

Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Puig C, Tirado-Vélez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Liñares J.

Antimicrob Agents Chemother. 2015 Jan;59(1):461-6. doi: 10.1128/AAC.04005-14. Epub 2014 Nov 10.

Supplemental Content

Support Center